BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260519
DTEND;VALUE=DATE:20260522
DTSTAMP:20260514T224352
CREATED:20260211T085701Z
LAST-MODIFIED:20260211T085701Z
UID:42865-1779148800-1779407999@www.pharmajournalist.com
SUMMARY:4th Nasal Formulation & Delivery Summit
DESCRIPTION:Biopharma investment into the formulation\, delivery\, and commercialization of intranasal therapies is at an all-time high\, and there has never been such an opportunistic time to pursue nasal delivery. Alongside the market projection for intranasal therapies being forecasted to reach $21.2 billion by 2032\, 2025 breakthroughs included Atzumi being approved for migraine treatment\, and Eli Lilly’s Baqsimi now being applied to severe Hypoglycemia. The clock is ticking for biopharma to master their formulations first time for systemic and CNS targeting\, streamline preclinical and clinical trial success\, and achieve regulatory approval to drive products to market. \nIn response to this recent momentum\, the 4th Nasal Formulation & Delivery Summit is uniting 70+ biopharma professionals across C-levels\, Formulation\, Intranasal\, and roduct Development to overcome drug and device combination challenges\, perfect preclinical translation\, and alter formulations\, to achieve commercial viability for intranasal products. This is the only forum specifically dedicated to industry-focused intranasal formulation\, targeting both systemic and CNS delivery. We will combine a hyper-relevant technical focus with a commercial angle to help see your products through concept to clinic. \nIn uniting large pharma\, expanding mid-sized biotech\, and startup innovators\, you will achieve technical excellence for your formulation and delivery that will future-proof commercialization\, and meet potential partners who will co-develop your intranasal therapies. Adopt groundbreaking insights on pre-clinical and clinical intranasal study data for different delivery methods to obtain practical takeaways that will transform the trajectory of your intranasal success. Join biopharma in igniting a new era of innovation where intranasal delivery holds the power to unparalleled medical benefits. \nTo know more visit: https://ter.li/eqlf0s
URL:http://www.pharmajournalist.com/event/4th-nasal-formulation-delivery-summit/
LOCATION:Hilton Boston Logan Airport\, One Hotel Dr\, Boston\, MA\, 02128\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260519
DTEND;VALUE=DATE:20260522
DTSTAMP:20260514T224352
CREATED:20260217T121251Z
LAST-MODIFIED:20260217T124142Z
UID:42916-1779148800-1779407999@www.pharmajournalist.com
SUMMARY:LEAP HR: Life Sciences West
DESCRIPTION:Returning for its 8th year\, LEAP HR: Life Sciences West brings together 100+ senior HR leaders from scaling and stabilizing biotech organizations to navigate volatility and drive measurable business impact. \nAcross three days of high-impact sessions\, including case studies\, benchmarking\, roundtables\, and structured networking\, attendees will gain practical strategies to build lean HR functions\, retain top talent\, and respond to immigration shifts and political change. \nThis is the only forum dedicated to the unique people challenges facing West Coast life sciences organizations. Join us this May to connect\, benchmark\, and lead with confidence in a rapidly evolving market. \nTo know more visit: https://ter.li/caoti5
URL:http://www.pharmajournalist.com/event/leap-hr-life-sciences-west-2026/
LOCATION:Wyndham San Diego Bayside\, 1355 N Harbor Dr\, San Diego\, CA\, 92101\, United States
ORGANIZER;CN="LEAP HR":MAILTO:leaphr@hansonwade.com
END:VEVENT
END:VCALENDAR